News | April 07, 2025
Fluor to provide EPCM services for pharmaceutical facility in Indiana
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Contracts are related to a $487 million biotech expansion project in Denmark and first phase of a new life sciences production facility valued at $574 million in Central U.S.
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
Construction is now underway with the facility scheduled to be operational by 2025
Subscribe To Our Newsletter & Stay Updated
